245 related articles for article (PubMed ID: 1350332)
1. [The medical therapy of peptic ulcer. The state of the art].
Perroni GB; De Matteis G; Pellizzeri F; Cassone A; Malara F
Minerva Chir; 1992 Apr; 47(7):607-12. PubMed ID: 1350332
[No Abstract] [Full Text] [Related]
2. [Concerning the discussion article by I. A. Morozov "Choice of the gastroenterologist"].
Gorshkov VA
Klin Med (Mosk); 2002; 80(9):66-70. PubMed ID: 12416232
[No Abstract] [Full Text] [Related]
3. [Peptic ulcer: current therapy].
Pieragnoli E
G Clin Med; 1987 Apr; 68(4):197-209. PubMed ID: 2886387
[No Abstract] [Full Text] [Related]
4. [Clinical, secretory, radiological and endoscopic evolution of patients with gastroduodenal ulcer treated with Ulcosilvanil, as compared with those treated with histamine H2 receptor antagonists].
Contraşiu P; Calinici V
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1980; 32(4):359-63. PubMed ID: 6113650
[No Abstract] [Full Text] [Related]
5. [Anti-H2 and omeprazole in brief therapy of peptic ulcer].
Piai G; Sabbatini F; Mazzacca G
Ann Ital Chir; 1990; 61(1):11-4. PubMed ID: 1978622
[No Abstract] [Full Text] [Related]
6. Pharmacologic options for the control of peptic ulcer disease.
Levine JB
Adv Intern Med; 1984; 30():425-47. PubMed ID: 6152108
[No Abstract] [Full Text] [Related]
7. [Losek (omeprazole), a new therapeutic agent in the treatment of peptic ulcer and hyperacidity states].
Bulgakov SA
Klin Med (Mosk); 1995; 73(5):11-6. PubMed ID: 8815266
[No Abstract] [Full Text] [Related]
8. [Lansoprazol].
Ponce J; Nos P
Gastroenterol Hepatol; 1995 Feb; 18(2):101-9. PubMed ID: 7621274
[No Abstract] [Full Text] [Related]
9. [Peptic ulcer and drug therapy].
Tsuneoka K
Nihon Naika Gakkai Zasshi; 1991 Jan; 80(1):1-2. PubMed ID: 1673699
[No Abstract] [Full Text] [Related]
10. [Gastric lesion caused by NSAID and inflammation due to Helicobacter pylori. Is there potentiation or attenuation?].
Lanas Arbeloa A; Serrano Aulló MT
Gastroenterol Hepatol; 1998 Jan; 21 Suppl 1():20-4. PubMed ID: 9549198
[No Abstract] [Full Text] [Related]
11. Omeprazole in acute and long-term treatment of Asian patients with peptic ulcer refractory to H2-antagonists.
Chelvam P; Wong EC
J Gastroenterol Hepatol; 1989; 4 Suppl 2():75-81. PubMed ID: 2577478
[TBL] [Abstract][Full Text] [Related]
12. [Which drug for peptic ulcer?].
Hameeteman W; Tytgat GN
Ned Tijdschr Geneeskd; 1985 Aug; 129(35):1673-6. PubMed ID: 2864643
[No Abstract] [Full Text] [Related]
13. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
Florent C
Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
[TBL] [Abstract][Full Text] [Related]
14. [Histamine H2-receptor antagonists as new anti-ulcer agents].
Takemoto T
Nihon Rinsho; 1984 Jan; 42(1):103-13. PubMed ID: 6143835
[No Abstract] [Full Text] [Related]
15. [What is the role of H2 receptor blockers today in ulcer therapy?].
Creutzfeldt W
Internist (Berl); 1996 Sep; 37(9):937-8. PubMed ID: 8964690
[No Abstract] [Full Text] [Related]
16. Recent advances in the treatment of digestive diseases.
Sun HS
J Int Med Res; 1989; 17 Suppl 1():2A-8A. PubMed ID: 2566540
[TBL] [Abstract][Full Text] [Related]
17. Medical treatment of peptic ulcer disease.
Andersen BN
Acta Chir Scand Suppl; 1988; 547():88-92. PubMed ID: 2906493
[TBL] [Abstract][Full Text] [Related]
18. [New therapy of peptic ulcer].
Harada T
Nihon Naika Gakkai Zasshi; 1995 Mar; 84(3):386-9. PubMed ID: 7751774
[No Abstract] [Full Text] [Related]
19. [Therapy and prevention of duodenal and gastric ulcer with histamine-H2-receptor antagonists].
Hentschel E
Wien Med Wochenschr; 1983; 133(4-5):104-7. PubMed ID: 6134397
[No Abstract] [Full Text] [Related]
20. [Drug therapy of peptic ulcer disease].
Pikkarainen P
Duodecim; 1991; 107(13):1097-102. PubMed ID: 1365337
[No Abstract] [Full Text] [Related]
[Next] [New Search]
